Aspire Wealth Management Corp »

Context Therapeutics shares owned by Aspire Wealth Management Corp

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Aspire Wealth Management Corp from 13F filings

Historical chart of Aspire Wealth Management Corp investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Aspire Wealth Management Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Aspire Wealth Management Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 10k 1.13
2023-09-30 $15k 10k 1.51
2023-06-30 $16k 10k 1.60
2023-03-31 $5.6k 10k 0.56
2022-12-31 $6.5k 10k 0.65

More positions owned by Aspire Wealth Management Corp

Invesco Exchange Traded Fd T S&p Mdcp Momntum (XMMO)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr Morningstar Grwt (ILCG)
Invesco Exchange Traded Fd T S&p Smcp Vlu Mnt (XSVM)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Wisdomtree Tr Itl Hdg Qtly Div (IHDG)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Ishares Tr Conv Bd Etf (ICVT)

View all positions for Aspire Wealth Management Corp

Top funds holding Context Therapeutics

Opaleye Management
Vanguard Group
HighTower Advisors
Clear Harbor Asset Management
Sheets Smith Wealth Management
Citadel Advisors
UBS Group
Advisor Group Holdings
Retirement Group
Wells Fargo & Company
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Context Therapeutics